138 related articles for article (PubMed ID: 30268734)
1. Therapeutic human papillomavirus vaccines in head and neck cancer: A systematic review of current clinical trials.
Schneider K; Grønhøj C; Hahn CH; von Buchwald C
Vaccine; 2018 Oct; 36(45):6594-6605. PubMed ID: 30268734
[TBL] [Abstract][Full Text] [Related]
2. Could the human papillomavirus vaccination be cost-effective in males for the prevention of oropharyngeal cancer?
Isaranuwatchai W; Graham DM; Siu LL; Hoch JS
Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):763-5. PubMed ID: 25095728
[TBL] [Abstract][Full Text] [Related]
3. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
Guo T; Eisele DW; Fakhry C
Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review.
Harder T; Wichmann O; Klug SJ; van der Sande MAB; Wiese-Posselt M
BMC Med; 2018 Jul; 16(1):110. PubMed ID: 30016957
[TBL] [Abstract][Full Text] [Related]
5. A survey of current practices, attitudes, and knowledge regarding human papillomavirus-related cancers and vaccines among head and neck surgeons.
Malloy KM; Ellender SM; Goldenberg D; Dolan RW
JAMA Otolaryngol Head Neck Surg; 2013 Oct; 139(10):1037-42. PubMed ID: 23989246
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic human papillomavirus vaccination.
Albers AE; Kaufmann AM
Public Health Genomics; 2009; 12(5-6):331-42. PubMed ID: 19684445
[TBL] [Abstract][Full Text] [Related]
7. The current state of therapeutic and T cell-based vaccines against human papillomaviruses.
Yang A; Farmer E; Lin J; Wu TC; Hung CF
Virus Res; 2017 Mar; 231():148-165. PubMed ID: 27932207
[TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus Associated Cancers of the Head and Neck: An Australian Perspective.
Aldalwg MAH; Brestovac B
Head Neck Pathol; 2017 Sep; 11(3):377-384. PubMed ID: 28176136
[TBL] [Abstract][Full Text] [Related]
9. Developments in L2-based human papillomavirus (HPV) vaccines.
Schellenbacher C; Roden RBS; Kirnbauer R
Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
Berman TA; Schiller JT
Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680
[TBL] [Abstract][Full Text] [Related]
11. Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck Cancer.
Whang SN; Filippova M; Duerksen-Hughes P
Viruses; 2015 Sep; 7(9):5040-65. PubMed ID: 26393639
[TBL] [Abstract][Full Text] [Related]
12. Effects of varying antigens and adjuvant systems on the immunogenicity and safety of investigational tetravalent human oncogenic papillomavirus vaccines: results from two randomized trials.
Van Damme P; Leroux-Roels G; Simon P; Foidart JM; Donders G; Hoppenbrouwers K; Levin M; Tibaldi F; Poncelet S; Moris P; Dessy F; Giannini SL; Descamps D; Dubin G
Vaccine; 2014 Jun; 32(29):3694-705. PubMed ID: 24674663
[TBL] [Abstract][Full Text] [Related]
13. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
14. [Human papilloma virus in head and neck cancer].
Barry B; Ortholan C
Cancer Radiother; 2014 Oct; 18(5-6):430-3. PubMed ID: 25151649
[TBL] [Abstract][Full Text] [Related]
15. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma.
Dalianis T
Presse Med; 2014 Dec; 43(12 Pt 2):e429-34. PubMed ID: 25455638
[TBL] [Abstract][Full Text] [Related]
17. Knowledge of HPV-Related Oropharyngeal Cancer and Use of Human Papillomavirus Vaccines by Pediatricians in Louisiana.
Mehta V; Holmes S; Master A; Leblanc B; Caldito LG; Bocchini J
J La State Med Soc; 2017; 169(2):37-42. PubMed ID: 28414659
[TBL] [Abstract][Full Text] [Related]
18. Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors.
Diniz MO; Cariri FA; Aps LR; Ferreira LC
Hum Gene Ther; 2013 Oct; 24(10):861-70. PubMed ID: 24007495
[TBL] [Abstract][Full Text] [Related]
19. HPV Infection of the Head and Neck Region and Its Stem Cells.
Pullos AN; Castilho RM; Squarize CH
J Dent Res; 2015 Nov; 94(11):1532-43. PubMed ID: 26353884
[TBL] [Abstract][Full Text] [Related]
20. HPV vaccination in head and neck HPV-related pathologies.
Wierzbicka M; Józefiak A; Jackowska J; Szydłowski J; Goździcka-Józefiak A
Otolaryngol Pol; 2014; 68(4):157-73. PubMed ID: 24981297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
